Avela™ (R)-1,3-Butanediol for Healthy Subjects

N/A

Waitlist Available

Research Sponsored by Genomatica Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0, 30, 60, 90, 120, 180, 240, and 300 minutes

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a special drink containing (R)-1,3-butanediol to see how it affects ketone levels in the blood. It also looks at how the drink impacts stomach comfort and alertness. The body turns (R)-1,3-butanediol into ketones, which can be used for energy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0, 30, 60, 90, 120, 180, 240, and 300 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0, 30, 60, 90, 120, 180, 240, and 300 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 30, 60, 90, 120, 180, 240, and 300 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

To evaluate the level of production of BHB measure of blood ketones levels (i.e., blood BHB levels)

Secondary study objectives

To assess GI symptomology

To assess Sleepiness/alertness

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Avela™ (R)-1,3-ButanediolExperimental Treatment1 Intervention

3 servings of Avela™, with consumption of each serving separated by 30 minutes and each serving providing 11.5 g of (R)-1,3-butanediol \[total intake of 34.5 g of (R)-1,3-butanediol\].

Do I qualify?Apply below to find out